SU-011,248
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SU-011,248, covering 2007-05-07 to 2007-05-07. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer [Phase 2]